Literature DB >> 25947376

Introduction to Thematic Minireview Series: Novel Bioactive Sphingolipids.

Alfred H Merrill1, George M Carman2.   

Abstract

Sphingosine was named by J. L. W. Thudichum for its enigmatic properties. This descriptor has applied to sphingolipids for over a century because new enigmas continue to surface. This JBC minireview series presents articles about three novel subspecies of sphingolipids, α-galactosylceramides, 4,5-dihydroceramides, and 1-deoxysphingolipids, that have important activities but, until recently, remained undetected (or at least understudied) in the shadow of very closely related compounds. They also serve as a reminder that important metabolites still lie "off the radar screen" in reports of global and comprehensive metabolomic profiling.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apoptosis; autophagy; cancer; cell signaling; ceramide; diabetes; glycolipid; immunology; neuropathy; sphingolipid

Mesh:

Substances:

Year:  2015        PMID: 25947376      PMCID: PMC4505448          DOI: 10.1074/jbc.R115.663708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Biochemistry of the sphingolipides; preparation of sphingolipides from beef brain and spinal cord.

Authors:  H E CARTER; W J HAINES
Journal:  J Biol Chem       Date:  1947-06       Impact factor: 5.157

Review 3.  A comprehensive classification system for lipids.

Authors:  Eoin Fahy; Shankar Subramaniam; H Alex Brown; Christopher K Glass; Alfred H Merrill; Robert C Murphy; Christian R H Raetz; David W Russell; Yousuke Seyama; Walter Shaw; Takao Shimizu; Friedrich Spener; Gerrit van Meer; Michael S VanNieuwenhze; Stephen H White; Joseph L Witztum; Edward A Dennis
Journal:  J Lipid Res       Date:  2005-02-16       Impact factor: 5.922

4.  Regulation of human EGF receptor by lipids.

Authors:  Ünal Coskun; Michał Grzybek; David Drechsel; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-13       Impact factor: 11.205

Review 5.  Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy.

Authors:  Wenjing Zheng; Jessica Kollmeyer; Holly Symolon; Amin Momin; Elizabeth Munter; Elaine Wang; Samuel Kelly; Jeremy C Allegood; Ying Liu; Qiong Peng; Harsha Ramaraju; M Cameron Sullards; Myles Cabot; Alfred H Merrill
Journal:  Biochim Biophys Acta       Date:  2006-08-22

6.  Glycolipids that elicit IFN-γ-biased responses from natural killer T cells.

Authors:  Aaron J Tyznik; Elisa Farber; Enrico Girardi; Alysia Birkholz; Yali Li; Sampada Chitale; Regina So; Pooja Arora; Archana Khurana; Jing Wang; Steven A Porcelli; Dirk M Zajonc; Mitchell Kronenberg; Amy R Howell
Journal:  Chem Biol       Date:  2011-12-23

Review 7.  Sphingolipid-binding proteins.

Authors:  C F Snook; J A Jones; Y A Hannun
Journal:  Biochim Biophys Acta       Date:  2006-07-04

8.  The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers.

Authors:  R Cuadros; E Montejo de Garcini; F Wandosell; G Faircloth; J M Fernández-Sousa; J Avila
Journal:  Cancer Lett       Date:  2000-04-28       Impact factor: 8.679

9.  Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.

Authors:  Florian S Eichler; Thorsten Hornemann; Alex McCampbell; Dika Kuljis; Anke Penno; Daniel Vardeh; Eric Tamrazian; Kevin Garofalo; Ho-Joon Lee; Lohit Kini; Martin Selig; Matthew Frosch; Ken Gable; Arnold von Eckardstein; Clifford J Woolf; Guiman Guan; Jeffrey M Harmon; Teresa M Dunn; Robert H Brown
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

10.  Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.

Authors:  Anke Penno; Mary M Reilly; Henry Houlden; Matilde Laurá; Katharina Rentsch; Vera Niederkofler; Esther T Stoeckli; Garth Nicholson; Florian Eichler; Robert H Brown; Arnold von Eckardstein; Thorsten Hornemann
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more
  5 in total

1.  Porphyromonas gingivalis Sphingolipid Synthesis Limits the Host Inflammatory Response.

Authors:  F G Rocha; Z D Moye; G Ottenberg; P Tang; D J Campopiano; F C Gibson; M E Davey
Journal:  J Dent Res       Date:  2020-02-27       Impact factor: 6.116

2.  Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Authors:  Daniel Steil; Catherine-Louise Schepers; Gottfried Pohlentz; Nadine Legros; Jana Runde; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2015-10-13       Impact factor: 5.922

3.  Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis.

Authors:  Eric M Brown; Xiaobo Ke; Daniel Hitchcock; Sarah Jeanfavre; Julian Avila-Pacheco; Toru Nakata; Timothy D Arthur; Nadine Fornelos; Cortney Heim; Eric A Franzosa; Nicki Watson; Curtis Huttenhower; Henry J Haiser; Glen Dillow; Daniel B Graham; B Brett Finlay; Aleksandar D Kostic; Jeffrey A Porter; Hera Vlamakis; Clary B Clish; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2019-05-08       Impact factor: 21.023

4.  Correlation of the plasma sphingoid base profile with results from oral glucose tolerance tests in gestational diabetes mellitus.

Authors:  Abad Khan; Thorsten Hornemann
Journal:  EXCLI J       Date:  2017-04-18       Impact factor: 4.068

Review 5.  Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate.

Authors:  Beatrice Arosio; Graziamaria Corbi; Sergio Davinelli; Vienna Giordano; Daniela Liccardo; Antonio Rapacciuolo; Alessandro Cannavo
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.